OFIX Quote, Financials, Valuation and Earnings

Picard Medical has a net margin of -11.09% compared to Orthofix Medical, Inc.'s net margin of --. Orthofix Medical, Inc.'s return on equity of -24.94% beat Picard Medical's return on equity of --.

Orthofix Medical, Inc. has a consensus price target of $22.80, signalling upside risk potential of 50.4%. On the other hand Picard Medical has an analysts' consensus of -- which suggests that it could fall by --. Given that Orthofix Medical, Inc. has higher upside potential than Picard Medical, analysts believe Orthofix Medical, Inc. is more attractive than Picard Medical.

Orthofix Medical, Inc. has a beta of 0.788, which suggesting that the stock is 21.22% less volatile than S&P 500. In comparison Picard Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Orthofix Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Picard Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Orthofix Medical, Inc. pays -- of its earnings as a dividend. Picard Medical pays out -- of its earnings as a dividend.

Orthofix Medical, Inc. quarterly revenues are $205.6M, which are larger than Picard Medical quarterly revenues of --. Orthofix Medical, Inc.'s net income of -$22.8M is higher than Picard Medical's net income of --. Notably, Orthofix Medical, Inc.'s price-to-earnings ratio is -- while Picard Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orthofix Medical, Inc. is 0.73x versus -- for Picard Medical. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of -11.09% compared to Orthofix Medical, Inc.'s net margin of -862.39%. Orthofix Medical, Inc.'s return on equity of -24.94% beat VolitionRX Ltd.'s return on equity of --.

Orthofix Medical, Inc. has a consensus price target of $22.80, signalling upside risk potential of 50.4%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 760.72%. Given that VolitionRX Ltd. has higher upside potential than Orthofix Medical, Inc., analysts believe VolitionRX Ltd. is more attractive than Orthofix Medical, Inc..

Orthofix Medical, Inc. has a beta of 0.788, which suggesting that the stock is 21.22% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.234, suggesting its more volatile than the S&P 500 by 23.404%.

Orthofix Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Orthofix Medical, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

Orthofix Medical, Inc. quarterly revenues are $205.6M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Orthofix Medical, Inc.'s net income of -$22.8M is lower than VolitionRX Ltd.'s net income of -$5.4M. Notably, Orthofix Medical, Inc.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orthofix Medical, Inc. is 0.73x versus 17.51x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision, Inc. has a net margin of -11.09% compared to Orthofix Medical, Inc.'s net margin of -1037.17%. Orthofix Medical, Inc.'s return on equity of -24.94% beat Catheter Precision, Inc.'s return on equity of -192.05%.

Orthofix Medical, Inc. has a consensus price target of $22.80, signalling upside risk potential of 50.4%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1976.57%. Given that Catheter Precision, Inc. has higher upside potential than Orthofix Medical, Inc., analysts believe Catheter Precision, Inc. is more attractive than Orthofix Medical, Inc..

Orthofix Medical, Inc. has a beta of 0.788, which suggesting that the stock is 21.22% less volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.392, suggesting its less volatile than the S&P 500 by 239.195%.

Orthofix Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Orthofix Medical, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.

Orthofix Medical, Inc. quarterly revenues are $205.6M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Orthofix Medical, Inc.'s net income of -$22.8M is lower than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Orthofix Medical, Inc.'s price-to-earnings ratio is -- while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orthofix Medical, Inc. is 0.73x versus 8.60x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -11.09% compared to Orthofix Medical, Inc.'s net margin of 3.93%. Orthofix Medical, Inc.'s return on equity of -24.94% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

Orthofix Medical, Inc. has a consensus price target of $22.80, signalling upside risk potential of 50.4%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 91.33%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Orthofix Medical, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than Orthofix Medical, Inc..

Orthofix Medical, Inc. has a beta of 0.788, which suggesting that the stock is 21.22% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.077, suggesting its less volatile than the S&P 500 by 107.701%.

Orthofix Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Orthofix Medical, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

Orthofix Medical, Inc. quarterly revenues are $205.6M, which are larger than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Orthofix Medical, Inc.'s net income of -$22.8M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Orthofix Medical, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 76.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orthofix Medical, Inc. is 0.73x versus 0.86x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.